表 1. Clinicopathological data of patients with NMIBC.

非肌层浸润性膀胱癌患者的临床病理资料

Clinicopathological variable	BCG group (n=72)	EPI group (n=21)	Total (n=93)	P
BCG: Bacillus Calmette–Guérin; EPI: Epirubicin; NMIBC: Non-muscle invasive bladder cancer; Recurrent≤1 rec/year: Prior recurrence rate of less than one per year; Recurrent>1 rec/year: Prior recurrence rate of more than one per year; EAU: European Association of Urology; EORTC: European Organization for Research and Treatment of Cancer; CUETO: Spanish Urological Club for Oncological Treatment.
Gender/case				0.390
Male	57	19	76
Female	15	2	17
Preoperative age/case				0.930
≤60 yr.	24	8	32
60−70 yr.	34	10	44
>70 yr.	14	3	17
Smoking history/case				0.089
No	43	8	51
Yes	29	13	42
Prior recurrence rate/case				0.232
Primary	44	13	57
Recurrent≤1 rec/year	18	2	20
Recurrent>1 rec/year	10	6	16
T stage/case				0.002
Ta	51	21	72
T1	21	0	21
Grade/case				0.331
Low	32	12	44
High	40	9	49
Tumor size/case				0.465
<3 cm	38	9	47
≥3 cm	34	12	46
Amount of tumors/case				0.793
≤3	49	13	62
>3	23	8	31
EAU risk stage/case				0.453
Intermediate	27	10	37
High	45	11	56
Recurrence/case				0.006
No	60	11	71
Yes	12	10	22
EORTC risk table/case				0.218
1−4	28	5	33
5−9	39	16	55
10−17	5	0	5
CUETO scoring model/case				0.962
0−4	21	7	28
5−6	26	8	35
7−9	20	5	25
10−16	5	1	6